Atossa Therapeutics, Inc. (ATOS)

Atossa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	71.08	88.46	110.89	136.38	39.55
Cash & Short-Term Investments	71.08	88.46	110.89	136.38	39.55
Cash Growth	-19.64%	-20.23%	-18.69%	244.79%	214.39%
Other Receivables	-	-	0.74	1.07	0.64
Receivables	-	-	0.74	1.07	0.64
Inventory	2.1	1.49	5.25	-	-
Prepaid Expenses	0.7	1.3	1.21	2.49	1.81
Restricted Cash	0.11	0.11	0.11	0.11	0.11
Other Current Assets	0.47	0.87	-	1.19	0.66
Total Current Assets	74.46	92.22	118.2	141.24	42.77
Property, Plant & Equipment	-	-	-	-	0.04
Long-Term Investments	-	1.71	4.7	-	-
Other Intangible Assets	-	-	-	-	0.01
Other Long-Term Assets	1.99	2.32	0.64	0.02	0.02
Total Assets	76.44	96.25	123.53	141.26	42.84
Accounts Payable	0.68	0.81	2.97	1.72	1.59
Accrued Expenses	2.78	2.63	2.58	1.39	1.06
Current Portion of Leases	-	-	-	-	0.02
Other Current Liabilities	1.51	1.8	0.02	0.02	13.01
Total Current Liabilities	4.97	5.24	5.57	3.13	15.67
Total Liabilities	4.97	5.24	5.57	3.13	15.67
Common Stock	23.49	22.79	22.79	22.79	8.56
Additional Paid-In Capital	261.26	255.99	251.37	244	129.89
Retained Earnings	-211.79	-186.29	-156.19	-129.23	-111.9
Treasury Stock	-1.48	-1.48	-	-	-
Total Common Equity	71.48	91.02	117.96	137.55	26.55
Shareholders' Equity	71.48	91.02	117.96	138.14	27.17
Total Liabilities & Equity	76.44	96.25	123.53	141.26	42.84
Total Debt	-	-	-	-	0.02
Net Cash (Debt)	71.08	88.46	110.89	136.38	39.54
Net Cash Growth	-19.64%	-20.23%	-18.69%	244.94%	215.51%
Net Cash Per Share	0.56	0.70	0.88	1.17	3.50
Filing Date Shares Outstanding	129.17	125.3	126.62	126.62	120.82
Total Common Shares Outstanding	129.17	125.3	126.62	126.62	47.55
Working Capital	69.49	86.98	112.63	138.11	27.1
Book Value Per Share	0.55	0.73	0.93	1.09	0.56
Tangible Book Value	71.48	91.02	117.96	137.55	26.53
Tangible Book Value Per Share	0.55	0.73	0.93	1.09	0.56
Machinery	-	-	-	-	0.19

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q